Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
about
Immunotherapy for brain cancer: recent progress and future promiseDecreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCT116 colorectal cancer cells.Recurrent respiratory papillomatosis: current and future perspectives.Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11.Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.Poly(I:C) induces controlled release of IL-36γ from keratinocytes in the absence of cell death.Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancer.T(H)2-like chemokine patterns correlate with disease severity in patients with recurrent respiratory papillomatosis.Differential control of Helios(+/-) Treg development by monocyte subsets through disparate inflammatory cytokinesHigh-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected womenTransient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.Associations of FoxP3 gene polymorphisms with severe recurrent respiratory papillomatosis in Korean patients.Redirecting the focus of cancer immunotherapy to premalignant conditions.Pembrolizumab: the value of PDL1 biomarker in head and neck cancer.PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis.Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells.Programmed death-1 (PD-1)-dependent functional impairment of CD4(+) T cells in recurrent genital papilloma.Prevalence of diabetes mellitus and its impact on disease severity in adult recurrent respiratory papillomatosis.The PD-1 and PD-L1 pathway in recurrent respiratory papillomatosis.Regulatory T cells in the actinic cheilitis.A Case Series of the Probability Density and Cumulative Distribution of Laryngeal Disease in a Tertiary Care Voice Center.The dawn of vaccines for cancer prevention.Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.Expression of PD-L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasionExpression of programmed death ligand-1 and programmed death-1 in samples of invasive ductal carcinoma of the breast and its correlation with prognosis
P2860
Q27015881-C1D6CC92-DA5E-4259-918A-FB68D3877F71Q34129757-70CF70F4-08C1-4909-B1DA-BD9F19740518Q35016870-8CEE58FD-87F8-466D-A23E-034160CDC258Q35592876-8998ABC3-5936-4A3B-8F9A-51BB704C215AQ35647677-34A528A6-769F-4BA5-956C-84A0A0A83FA3Q35837683-4D61AE00-0BFA-4B0B-8387-36A32647B7AAQ36289982-DC7D297F-7F7F-47B4-A2A3-C21368F5185CQ36336136-C760CDB9-29C3-430A-AAF8-0B65D6B52660Q36465254-F148B6DF-AAE2-47E1-B98D-E906B0393CC2Q36730422-5925F71F-C85E-43AB-A104-DECE083F5688Q37012660-57A41A4E-D11E-4030-83E6-86C0F606D8B5Q37664203-A73913F8-1C49-43DE-9050-EFD724F58279Q37704974-1168ED6C-D049-43A6-B1AB-6AD3BCEB6B0EQ39107022-326FCD8D-7D54-44DB-8A4F-7925869813BCQ40654130-2EA04C92-6D3A-4C36-8A94-B637598C8B47Q41439865-E42C9EA7-B377-4EDA-9A95-89E54FA1D08EQ42233712-77352D2A-5036-4E8C-B2C6-0021E105651EQ42256500-27C04C28-F865-4D86-B3B1-8D938D95314BQ42284007-AE1CA8F6-5820-433A-8469-22512E6D0AFCQ42515661-84F3594B-9885-4C50-A002-91186C1708E2Q46002993-D921E576-9C87-4835-859C-01A3314732A6Q47761746-504BB934-005F-49E4-99AE-35467D03D4F2Q49566629-6C7BC067-BA8E-4B79-9065-01D16D397D3FQ55432051-F86B5B6A-C17B-49F8-A9B4-25B9A05494CDQ58573003-A9DCA734-B566-4207-B801-78956642FA60Q58740225-8E407AED-696D-4A3B-9E01-82B7848EB1F3
P2860
Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immune suppression in premalig ...... and PD-1/PD-L1/L2 expression.
@ast
Immune suppression in premalig ...... and PD-1/PD-L1/L2 expression.
@en
type
label
Immune suppression in premalig ...... and PD-1/PD-L1/L2 expression.
@ast
Immune suppression in premalig ...... and PD-1/PD-L1/L2 expression.
@en
prefLabel
Immune suppression in premalig ...... and PD-1/PD-L1/L2 expression.
@ast
Immune suppression in premalig ...... and PD-1/PD-L1/L2 expression.
@en
P2093
P2860
P1476
Immune suppression in premalig ...... and PD-1/PD-L1/L2 expression.
@en
P2093
Allan L Abramson
David W Rosenthal
James A Devoti
Lynda J Hatam
P2860
P304
P356
10.1158/1078-0432.CCR-11-2941
P407
P577
2012-02-09T00:00:00Z